Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.

作者: Shan Xing , Zhi Tian , Wenying Zheng , Wenjuan Yang , Nan Du

DOI: 10.1186/S12943-020-01295-2

关键词: microRNACellTumor progressionMetastasisCancer researchReverse transcription polymerase chain reactionBiologySNAI1In vivoFOXM1

摘要: MicroRNAs (miRNAs) show considerable promise as therapeutic agents to improve tumor treatment, they have been revealed crucial modulators in progression. However, our understanding of their roles gastric carcinoma (GC) metastasis is limited. Here, we aimed identify novel miRNAs involved GC and explored regulatory mechanisms significance GC. The microRNA expression profiles tumors at different stages statuses were compared respectively using the stomach adenocarcinoma (STAD) miRNASeq dataset TCGA. Using above method, miR-4521 was picked out for further study. tissues examined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) situ hybridization (ISH). Highly lowly invasive cell sublines established a repetitive transwell assay. Gain-of-function loss-of-function analyses performed investigate functions its upstream downstream vitro vivo. Moreover, investigated role mouse xenograft model. In this study, found that downregulated with adjacent normal downregulation positively correlated advanced clinical stage, status poor patient prognosis. Functional experiments inhibited invasion Further studies showed hypoxia repressed via inducing ETS1 mitigated hypoxia-mediated metastasis, while inactivated AKT/GSK3β/Snai1 pathway targeting IGF2 FOXM1, thereby inhibiting epithelial-mesenchymal transition (EMT) process metastasis. addition, demonstrated delivery synthetic suppressed progression Our results suggest an important regulating hypoxic response cells well miRNA

参考文章(55)
Adrian L. Harris, Hypoxia — a key regulatory factor in tumour growth Nature Reviews Cancer. ,vol. 2, pp. 38- 47 ,(2002) , 10.1038/NRC704
Hong Zhuang, Rong Zhang, Shujie Zhang, Qinmeng Shu, Dan Zhang, Gezhi Xu, Altered expression of microRNAs in the neuronal differentiation of human Wharton’s Jelly mesenchymal stem cells Neuroscience Letters. ,vol. 600, pp. 69- 74 ,(2015) , 10.1016/J.NEULET.2015.05.061
Hyun Jung Park, Galina Gusarova, Zebin Wang, Janai R. Carr, Jing Li, Ki‐Hyun Kim, Jin Qiu, Yoon‐Dong Park, Peter R. Williamson, Nissim Hay, Angela L. Tyner, Lester F. Lau, Robert H. Costa, Pradip Raychaudhuri, Deregulation of FoxM1b leads to tumour metastasis. Embo Molecular Medicine. ,vol. 3, pp. 21- 34 ,(2011) , 10.1002/EMMM.201000107
Sohail F. Tavazoie, Claudio Alarcón, Thordur Oskarsson, David Padua, Qiongqing Wang, Paula D. Bos, William L. Gerald, Joan Massagué, Endogenous human microRNAs that suppress breast cancer metastasis Nature. ,vol. 451, pp. 147- 152 ,(2008) , 10.1038/NATURE06487
Phong Trang, Jason F Wiggins, Christopher L Daige, Chris Cho, Michael Omotola, David Brown, Joanne B Weidhaas, Andreas G Bader, Frank J Slack, Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice Molecular Therapy. ,vol. 19, pp. 1116- 1122 ,(2011) , 10.1038/MT.2011.48
Witold Filipowicz, Suvendra N. Bhattacharyya, Nahum Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics. ,vol. 9, pp. 102- 114 ,(2008) , 10.1038/NRG2290
Pradip Raychaudhuri, Hyun Jung Park, FoxM1: A Master Regulator of Tumor Metastasis Cancer Research. ,vol. 71, pp. 4329- 4333 ,(2011) , 10.1158/0008-5472.CAN-11-0640
Jason F. Wiggins, Lynnsie Ruffino, Kevin Kelnar, Michael Omotola, Lubna Patrawala, David Brown, Andreas G. Bader, Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Research. ,vol. 70, pp. 5923- 5930 ,(2010) , 10.1158/0008-5472.CAN-10-0655
Binhua P. Zhou, Jiong Deng, Weiya Xia, Jihong Xu, Yan M. Li, Mehmet Gunduz, Mien-Chie Hung, Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition Nature Cell Biology. ,vol. 6, pp. 931- 940 ,(2004) , 10.1038/NCB1173